Immunology Flashcards

1
Q

19 year old male presents to A&E with severe respiratory difficulty, light-headedness and a red itchy rash. On examination he has laryngeal oedema, bilateral wheezing across the lung fields and is hypotensive. He has recently been taking antibiotics for a chest infection.

All Answer Choices
A. Acute Urticaria
B. Food allergy
C. Chronic Urticaria
D. Allergic asthma
E. Anaphylaxis
F. Contact dermatitis
G. Drug allergy
H. Allergic Rhinitis
I. Angioedema
J. Allergic bronchopulmonary Aspergillosis
A

E. Anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A 3 year old girl is brought into A&E by her parents. She has had vomiting and diarrhoea since early yesterday evening when she was at a birthday party. On examination she has urticaria.

All Answer Choices
A. Acute Urticaria
B. Food allergy
C. Chronic Urticaria
D. Allergic asthma
E. Anaphylaxis
F. Contact dermatitis
G. Drug allergy
H. Allergic Rhinitis
I. Angioedema
J. Allergic bronchopulmonary Aspergillosis
A

B. Food allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A 40 year old man presents to his GP complaining of loss smell and nasal itching and discharge. On examination his nasal mucosa are swollen and have a bluish tinge. His symptoms improve with a corticosteroid spray

All Answer Choices
A. Acute Urticaria
B. Food allergy
C. Chronic Urticaria
D. Allergic asthma
E. Anaphylaxis
F. Contact dermatitis
G. Drug allergy
H. Allergic Rhinitis
I. Angioedema
J. Allergic bronchopulmonary Aspergillosis
A

H. Allergic Rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A 25 year old woman presents to her GP complaining of itchy, red wheals on her torso which have been present for 7 weeks. She can not remember how they started but has noticed they are worse in the heat and when she exercises.

All Answer Choices
A. Acute Urticaria
B. Food allergy
C. Chronic Urticaria
D. Allergic asthma
E. Anaphylaxis
F. Contact dermatitis
G. Drug allergy
H. Allergic Rhinitis
I. Angioedema
J. Allergic bronchopulmonary Aspergillosis
A

C. Chronic Urticaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A 30 year old women presents to her GP with a red, itchy, oozing rash around her neck and fingers

All Answer Choices
A. Acute Urticaria
B. Food allergy
C. Chronic Urticaria
D. Allergic asthma
E. Anaphylaxis
F. Contact dermatitis
G. Drug allergy
H. Allergic Rhinitis
I. Angioedema
J. Allergic bronchopulmonary Aspergillosis
A

F. Contact dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A 55 year old man with history of angina was advised to take a tablet before a long flight. After taking the pill, he suddenly finds that he has difficulty breathing, feels nauseous and is itching.

All Answer Choices
A. Chronic urticaria
B. C1 inhibitor deficiency
C. Idiopathic angioedema
D. Panic attack
E. Acute urticaria
F. IgE mediated anaphylaxis
G. Coeliac disease
H. Extrinsic allergic alveolitis
I. Mast cell degranulation
J. Allergic asthma
K. Urticarial vasculitis
A

I. Mast cell degranulation

Mast cell degranulation is not IgE mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A 24 year old medical student develops worsening swelling of the hands and feet and abdominal pain before her final year medical exams. She says that similar milder episodes have occurred preciously.

All Answer Choices
A. Chronic urticaria
B. C1 inhibitor deficiency
C. Idiopathic angioedema
D. Panic attack
E. Acute urticaria
F. IgE mediated anaphylaxis
G. Coeliac disease
H. Extrinsic allergic alveolitis
I. Mast cell degranulation
J. Allergic asthma
K. Urticarial vasculitis
A

B. C1 inhibitor deficiency

The simple answer is that C1 inhibitor has a number of functions, in addition to inhibiting the activation of C1. For example,
it also inhibits activation of the kinin pathway, the clotting pathway and the fibrinolytic pathway. It does this through
inhibition of factor XII, activated factor XI, and kallikrein as well as C1.

It’s likely that activation of the kinin pathway and production of bradykinin mediates the angioedema associated with this
condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A 50 year old Irish woman presents to her GP with episodes of diarrhoea, which is difficult to flush, abdominal pain, weight loss and fatigue. She also describes a blistering itchy rash on her knees.

All Answer Choices
A. Chronic urticaria
B. C1 inhibitor deficiency
C. Idiopathic angioedema
D. Panic attack
E. Acute urticaria
F. IgE mediated anaphylaxis
G. Coeliac disease
H. Extrinsic allergic alveolitis
I. Mast cell degranulation
J. Allergic asthma
K. Urticarial vasculitis
A

G. Coeliac disease

Coeliac disease is associated with a superficial, blistering skin rash ‘dermatitis herpetiformis’, which is intensely itchy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A 26 year old male who has been suffering from ‘flu-like’ symptoms with fever presents to the GP after developing skin rash in the last few days.

All Answer Choices
A. Chronic urticaria
B. C1 inhibitor deficiency
C. Idiopathic angioedema
D. Panic attack
E. Acute urticaria
F. IgE mediated anaphylaxis
G. Coeliac disease
H. Extrinsic allergic alveolitis
I. Mast cell degranulation
J. Allergic asthma
K. Urticarial vasculitis
A

E. Acute urticaria

Acute urticaria is defined being present for less than 6 weeks, whereas chronic urticaria persists
for more than 6 weeks. In both cases the urticarial rash is intermittent, comes and goes and normally
persists in a single site for less than 24 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A 35 year old woman presents with persistent itchy wheels for the last 2 months. She noticed that when this is at its worst, she also has a fever and feels generally unwell. After an acute attack, she has bruising and post-inflammatory residual pigmentation at the site of the itching.

All Answer Choices
A. Chronic urticaria
B. C1 inhibitor deficiency
C. Idiopathic angioedema
D. Panic attack
E. Acute urticaria
F. IgE mediated anaphylaxis
G. Coeliac disease
H. Extrinsic allergic alveolitis
I. Mast cell degranulation
J. Allergic asthma
K. Urticarial vasculitis
A

K. Urticarial vasculitis

Urticarial rashes that last more than 24 hours in a single site, resolve with bruising or skin depigmentation
may raise the possibility of an underlying vasculitis. In this instance a skin biopsy of the urticarial
lesion is useful to confirm/repute presence of a vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A 19 year old male presents to A&E with increasing breathlessness. On examination his blood pressure is 90/55 mmHg and his respiratory rate is 28/min. He shows you a generalised red itchy skin rash, and examination of his chest reveals bilateral inspiratory and expiratory wheezes throughout.

All Answer Choices
A. Hereditary angioedema
B. Allergic bronchopulmonary aspergillosis
C. Allergic rhinitis
D. Anaphylaxis
E. Acute angioedema
F. Allergic conjunctivitis
G. Contact hypersensitivity
H. Chronic urticaria
I. Allergic asthma
J. Acute urticaria
A

D. Anaphylaxis

The combination of hypotension, respiratory distress, urticaria and bronchoconstriction is very suggestive of anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A 35 year old woman presents with a two day history of a red itchy skin rash which started soon after her first scuba-diving lesson. She is otherwise well.

All Answer Choices
A. Hereditary angioedema
B. Allergic bronchopulmonary aspergillosis
C. Allergic rhinitis
D. Anaphylaxis
E. Acute angioedema
F. Allergic conjunctivitis
G. Contact hypersensitivity
H. Chronic urticaria
I. Allergic asthma
J. Acute urticaria
A

J. Acute urticaria

This rash is very suggestive of acute urticaria. The temporal association with scuba diving may indicate an allergy to latex (in wet suits).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A 22 year old woman presents with an intermittently itchy and desquamating skin rash on her abdomen which is unresponsive to antihistamines

All Answer Choices
A. Hereditary angioedema
B. Allergic bronchopulmonary aspergillosis
C. Allergic rhinitis
D. Anaphylaxis
E. Acute angioedema
F. Allergic conjunctivitis
G. Contact hypersensitivity
H. Chronic urticaria
I. Allergic asthma
J. Acute urticaria
A

G. Contact hypersensitivity

This rash is typical of contact hypersensitivity. The distribution of the rash suggests that the specific agent is nickel, which used to be a component of the studs of jeans and is commonly found in the metal used in belts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A 40 year old man complains of loss of smell with nasal itching and discharge over 4 weeks. He also describes morning sneezing. He is otherwise in good health. On examination his nasal mucosa are swollen and hyperaemic.

All Answer Choices
A. Hereditary angioedema
B. Allergic bronchopulmonary aspergillosis
C. Allergic rhinitis
D. Anaphylaxis
E. Acute angioedema
F. Allergic conjunctivitis
G. Contact hypersensitivity
H. Chronic urticaria
I. Allergic asthma
J. Acute urticaria
A

C. Allergic rhinitis

The combination of sneezing, rhinorrhea and loss of smell is very suggestive of allergic rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

This 45 year old woman presents to A&E with tongue swelling and acute respiratory tract obstruction. She has longstanding hypertension and received a renal transplant two years previously. She has no history of allergic disease. On examination her blood pressure is stable, and examination of her lung fields reveal normal breath sounds. Her current medication includes cyclosporine, azathioprine, captopril and nifedipine.

All Answer Choices
A. Hereditary angioedema
B. Allergic bronchopulmonary aspergillosis
C. Allergic rhinitis
D. Anaphylaxis
E. Acute angioedema
F. Allergic conjunctivitis
G. Contact hypersensitivity
H. Chronic urticaria
I. Allergic asthma
J. Acute urticaria
A

E. Acute angioedema

This woman has angioedema of the tongue, without symptoms suggestive of a generalised allergic reaction. Isolated angioedema may be allergic in origin, but 94% of cases angioedema presenting to A&E are drug induced and the majority of these are associated with ACE inhibitors (eg captopril).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A 19 year old male presents to A&E with increasing breathlessness. On examination his blood pressure is 90/55 mmHg and his respiratory rate is 28/min. He shows you a generalised red itchy skin rash, and examination of his chest reveals bilateral inspiratory and expiratory wheezes throughout.

A. IV adrenaline 0.3mL of 1:1000
B. IM adrenaline 1mL of 1:10000
C. Inhaled antihistamines
D. IM adrenaline 1mL of 1:1000
E. Intraarticular corticosteroids
F. Venom immunotherapy
G. IM adrenaline 0.5 mL of 1:1000
H. PO antihistamines
I. Inhaled corticosteroids
J. None of the above
K. Intranasal antihistamines
L. IV antihistamines
M. Intracardiac adrenaline
A

D. IM adrenaline 1mL of 1:1000

The most important treatment of anaphylaxis is adrenaline, which should be given intramuscularly. (Note for final year pharm: 1:1000 means 1mg/mL; 1:10000 means 0.1mg/mL ; 1% means 1g/dL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A 35 year old woman presents with a two day history of a red itchy skin rash which started soon after her first scuba-diving lesson. She is otherwise well.

A. IV adrenaline 0.3mL of 1:1000
B. IM adrenaline 1mL of 1:10000
C. Inhaled antihistamines
D. IM adrenaline 1mL of 1:1000
E. Intraarticular corticosteroids
F. Venom immunotherapy
G. IM adrenaline 0.5 mL of 1:1000
H. PO antihistamines
I. Inhaled corticosteroids
J. None of the above
K. Intranasal antihistamines
L. IV antihistamines
M. Intracardiac adrenaline
A

H. PO antihistamines

  1. Severe acute urticaria is effectively treated with a short course of oral anti-histamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A 22 year old woman is presents with this intermittently itchy and desquamating skin rash which is unresponsive to antihistamines

A. IV adrenaline 0.3mL of 1:1000
B. IM adrenaline 1mL of 1:10000
C. Inhaled antihistamines
D. IM adrenaline 1mL of 1:1000
E. Intraarticular corticosteroids
F. Venom immunotherapy
G. IM adrenaline 0.5 mL of 1:1000
H. PO antihistamines
I. Inhaled corticosteroids
J. None of the above
K. Intranasal antihistamines
L. IV antihistamines
M. Intracardiac adrenaline
A

J. None of the above

Contact hypersensitivity should be treated by avoidance of the sensitising agent, in this case nickel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

This 45 year old woman presents to A&E with tongue swelling and acute respiratory tract obstruction. She has longstanding hypertension and received a renal transplant two years previously. She has no history of allergic disease. On examination her blood pressure is stable, and examination of her lung fields reveal normal breath sounds. Her current medication includes cyclosporine, azathioprine, captopril and nifedipine.

A. IV adrenaline 0.3mL of 1:1000
B. IM adrenaline 1mL of 1:10000
C. Inhaled antihistamines
D. IM adrenaline 1mL of 1:1000
E. Intraarticular corticosteroids
F. Venom immunotherapy
G. IM adrenaline 0.5 mL of 1:1000
H. PO antihistamines
I. Inhaled corticosteroids
J. None of the above
K. Intranasal antihistamines
L. IV antihistamines
M. Intracardiac adrenaline
A

IM adrenaline 0.5 mL of 1:1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A 40 year old man complains of loss of smell with nasal itching and discharge over 4 weeks. He also describes morning sneezing. He is otherwise in good health. On examination his nasal mucosa are swollen and hyperaemic.

A. IV adrenaline 0.3mL of 1:1000
B. IM adrenaline 1mL of 1:10000
C. Inhaled antihistamines
D. IM adrenaline 1mL of 1:1000
E. Intraarticular corticosteroids
F. Venom immunotherapy
G. IM adrenaline 0.5 mL of 1:1000
H. PO antihistamines
I. Inhaled corticosteroids
J. None of the above
K. Intranasal antihistamines
L. IV antihistamines
M. Intracardiac adrenaline
A

PO antihistamines

Oral antihistamines and intranasal corticosteroids are the mainstay of treatment of mild allergic rhinitis. (As intranasal corticosteroid is not an option available, the “single best” answer here is oral antihistamines.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cytokines exerting an anti-viral effect

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

E. Interferons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Immunoglobulin dimer

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

D. IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MHC associated with Th1 cells

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

F. Major histocompatability complex class 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Acts on hepatocytes to induce synthesis of acute phase proteins in response to bacterial infection

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

J. IL6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Arise in the first few days after infection and are important in defence against viruses and tumors

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

B. Natural Killer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

MHC associated with Th2 cells

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

F. Major histocompatability complex class 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

MHC associated with cytotoxic T cells

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

G. Major histocompatability complex class 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Along with IgD, is one of the first immunoglobulins expressed on B cells before they undergo antibody class switching

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

C. IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

The most abundant (in terms of g/L) immunoglobulin in normal plasma

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

I. IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Deficiencies in this predispose to SLE

A. Alternative complement pathway
B. Natural Killer cells
C. IgM
D. IgA
E. Interferons
F. Major histocompatability complex class 2
G. Major histocompatability complex class 1
H. Classical complement pathway
I. IgG
J. IL6
K. IgE
L. Innate immune system
M. CD8+
A

H. Classical complement pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Kostmanns syndrome is a congenital deficiency of which component of the immune system?

All Answer Choices
A. Bacterial
B. B lymphocyte
C. MHC Class I
D. T lymphocyte
E. Neutrophil
F. MHC Class II
G. Fungal
H. Complement
I. Viral
J. Mast cell
K. Parasitic
A

E. Neutrophil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Which component of the innate immune system is usually one of the first to respond to infection through a cut?

All Answer Choices
A. Bacterial
B. B lymphocyte
C. MHC Class I
D. T lymphocyte
E. Neutrophil
F. MHC Class II
G. Fungal
H. Complement
I. Viral
J. Mast cell
K. Parasitic
A

E. Neutrophil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Which infection is most common as a consequence of B cell deficiency?

All Answer Choices
A. Bacterial
B. B lymphocyte
C. MHC Class I
D. T lymphocyte
E. Neutrophil
F. MHC Class II
G. Fungal
H. Complement
I. Viral
J. Mast cell
K. Parasitic
A

A. Bacterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Meningococcal infections are quite common as a result of which deficiency of the component of the immune system?

All Answer Choices
A. Bacterial
B. B lymphocyte
C. MHC Class I
D. T lymphocyte
E. Neutrophil
F. MHC Class II
G. Fungal
H. Complement
I. Viral
J. Mast cell
K. Parasitic
A

H. Complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Produced by the liver, when triggered, enzymatically activate other proteins in a biological cascade and are important in innate and antibody mediated immune response?

All Answer Choices
A. Bacterial
B. B lymphocyte
C. MHC Class I
D. T lymphocyte
E. Neutrophil
F. MHC Class II
G. Fungal
H. Complement
I. Viral
J. Mast cell
K. Parasitic
A

H. Complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

A complete deficiency in this molecule is associated with recurrent respiratory and gastrointestinal infections.

All Answer Choices
A. C3a
B. Macrophages
C. AP50
D. IgM
E. IgG
F. NADPH oxidoase
G. CH50
H. Myeloperoxidase
I. MAC
J. C3b
K. IgA
L. C1
M. Neutrophils
A

K. IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Leukocyte Adhesion Deficiency is characterised by a very high count in which ?

All Answer Choices
A. C3a
B. Macrophages
C. AP50
D. IgM
E. IgG
F. NADPH oxidoase
G. CH50
H. Myeloperoxidase
I. MAC
J. C3b
K. IgA
L. C1
M. Neutrophils
A

M. Neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Which crucial enzyme is vital for the oxidative killing of intracellular micro-organisms?

All Answer Choices
A. C3a
B. Macrophages
C. AP50
D. IgM
E. IgG
F. NADPH oxidoase
G. CH50
H. Myeloperoxidase
I. MAC
J. C3b
K. IgA
L. C1
M. Neutrophils
A

F. NADPH oxidoase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Which complement factor is an important chemotaxic agent?

All Answer Choices
A. C3a
B. Macrophages
C. AP50
D. IgM
E. IgG
F. NADPH oxidoase
G. CH50
H. Myeloperoxidase
I. MAC
J. C3b
K. IgA
L. C1
M. Neutrophils
A

A. C3a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the functional complement test used to investigate the classical pathway?

All Answer Choices
A. C3a
B. Macrophages
C. AP50
D. IgM
E. IgG
F. NADPH oxidoase
G. CH50
H. Myeloperoxidase
I. MAC
J. C3b
K. IgA
L. C1
M. Neutrophils
A

G. CH50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the functional complement test used to investigate the classical pathway?

All Answer Choices
A. C3a
B. Macrophages
C. AP50
D. IgM
E. IgG
F. NADPH oxidoase
G. CH50
H. Myeloperoxidase
I. MAC
J. C3b
K. IgA
L. C1
M. Neutrophils
A

G. CH50

42
Q

Graves Disease

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

E. Type II – Antibody mediated

43
Q

SLE

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

G. Type III – Immune complex mediated

44
Q

Rheumatoid arthritis

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

B. Type IV – T-cell mediated

45
Q

Asthma

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

H. Not an autoimmune disease

46
Q

Type 1 diabetes

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

B. Type IV – T-cell mediated

47
Q

Immune thrombocytopaenic purpura

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

E. Type II – Antibody mediated

48
Q

ABO hemolytic transfusion reaction

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

E. Type II – Antibody mediated

49
Q

Hepatitis C associated membranoproliferative glomerulonephritis type I

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

G. Type III – Immune complex mediated

50
Q

Goodpasture’s syndrome

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

E. Type II – Antibody mediated

51
Q

Myaesthenia gravis

A. Type III – complement mediated
B. Type IV – T-cell mediated
C. Type II – Antigen mediated
D. Type III – T-cell mediated
E. Type II – Antibody mediated
F. Type IV – Complement mediated
G. Type III – Immune complex mediated
H. Not an autoimmune disease
A

E. Type II – Antibody mediated

52
Q

Systemic lupus erythematous

A. Rheumatoid factor
B. Anti-cardiolipin antibody
C. Anti-GAD antibody
D. Anti-centromere antibody
E. Coomb's test
F. Anti-CCP antibody
G. p-ANCA
H. Anti-mitochondrial antibody
I. Anti-nuclear antibody
J. c-ANCA
K. Anti-DNA antibody
A

K. Anti-DNA antibody

The rationale for the answer for SLE being anti-DNA antibody rather than ANA is that whilst ANA is very sensitive for SLE, it is not specific. Anti-DNA, in contrast, is highly specific to SLE (~95%).

53
Q

Wegener’s granulomatosis

A. Rheumatoid factor
B. Anti-cardiolipin antibody
C. Anti-GAD antibody
D. Anti-centromere antibody
E. Coomb's test
F. Anti-CCP antibody
G. p-ANCA
H. Anti-mitochondrial antibody
I. Anti-nuclear antibody
J. c-ANCA
K. Anti-DNA antibody
A

J. c-ANCA

c-ANCA matches with Wegener’s Granulomatosis, whilst p-ANCA would match with polyarteritis nodosa

54
Q

Rheumatoid arthritis

A. Rheumatoid factor
B. Anti-cardiolipin antibody
C. Anti-GAD antibody
D. Anti-centromere antibody
E. Coomb's test
F. Anti-CCP antibody
G. p-ANCA
H. Anti-mitochondrial antibody
I. Anti-nuclear antibody
J. c-ANCA
K. Anti-DNA antibody
A

F. Anti-CCP antibody

Rheumatoid factor is not specific or sensitive to rheumatoid arthritis and is common in the elderly. Anti-CCP is a more specific test for rheumatoid arthritis and a better predictor of an aggressive course.

55
Q

Auto-immune haemolytic anaemia

A. Rheumatoid factor
B. Anti-cardiolipin antibody
C. Anti-GAD antibody
D. Anti-centromere antibody
E. Coomb's test
F. Anti-CCP antibody
G. p-ANCA
H. Anti-mitochondrial antibody
I. Anti-nuclear antibody
J. c-ANCA
K. Anti-DNA antibody
A

E. Coomb’s test

56
Q

Primary biliary cirrhosis

A. Rheumatoid factor
B. Anti-cardiolipin antibody
C. Anti-GAD antibody
D. Anti-centromere antibody
E. Coomb's test
F. Anti-CCP antibody
G. p-ANCA
H. Anti-mitochondrial antibody
I. Anti-nuclear antibody
J. c-ANCA
K. Anti-DNA antibody
A

H. Anti-mitochondrial antibody

57
Q

Primary biliary cirrhosis

A. Rheumatoid factor
B. Anti-cardiolipin antibody
C. Anti-GAD antibody
D. Anti-centromere antibody
E. Coomb's test
F. Anti-CCP antibody
G. p-ANCA
H. Anti-mitochondrial antibody
I. Anti-nuclear antibody
J. c-ANCA
K. Anti-DNA antibody
A

H. Anti-mitochondrial antibody

58
Q

What is the specific auto-antigen that is the target of the immune system?

A. Lung
B. Ciclosporin
C. Type II collagen
D. Prednisolone
E. Anti-neutrophil cytoplasmic antibodies
F. Lumpy-bumpy pattern
G. Plasmapheresis
H. Smooth linear pattern
I. Type II Hypersentivity
J. Glomerular basement membrane
K. Type IV collagen
L. Mesangium
M. Skin
N. Blood vessels
A

K. Type IV collagen

59
Q

The pattern of the antibody deposition in the glomerular basement membrane is typically described as what?

A. Lung
B. Ciclosporin
C. Type II collagen
D. Prednisolone
E. Anti-neutrophil cytoplasmic antibodies
F. Lumpy-bumpy pattern
G. Plasmapheresis
H. Smooth linear pattern
I. Type II Hypersentivity
J. Glomerular basement membrane
K. Type IV collagen
L. Mesangium
M. Skin
N. Blood vessels
A

H. Smooth linear pattern

60
Q

Name the drug most likely to be used in the treatment of this disease.

A. Lung
B. Ciclosporin
C. Type II collagen
D. Prednisolone
E. Anti-neutrophil cytoplasmic antibodies
F. Lumpy-bumpy pattern
G. Plasmapheresis
H. Smooth linear pattern
I. Type II Hypersentivity
J. Glomerular basement membrane
K. Type IV collagen
L. Mesangium
M. Skin
N. Blood vessels
A

D. Prednisolone

61
Q

Immune damage may be associated with the kidney and commonly which other tissue?

A. Lung
B. Ciclosporin
C. Type II collagen
D. Prednisolone
E. Anti-neutrophil cytoplasmic antibodies
F. Lumpy-bumpy pattern
G. Plasmapheresis
H. Smooth linear pattern
I. Type II Hypersentivity
J. Glomerular basement membrane
K. Type IV collagen
L. Mesangium
M. Skin
N. Blood vessels
A

A. Lung

62
Q

X-Linked Agammaglobulinaemia

A.	CD3 mutation
B.	IL-2 receptor
C.	Bruton’s tyrosine kinase (Btk) gene
D.	MHC Class II
E.	WASP gene
F.	IFN Receptor 1 gene
G.	Chromosome 22q11
H.	IL12 gene
I.	CD40 Ligand gene
A

C. Bruton’s tyrosine kinase (Btk) gene

63
Q

DiGeorge’s Syndrome

A.	CD3 mutation
B.	IL-2 receptor
C.	Bruton’s tyrosine kinase (Btk) gene
D.	MHC Class II
E.	WASP gene
F.	IFN Receptor 1 gene
G.	Chromosome 22q11
H.	IL12 gene
I.	CD40 Ligand gene
A

G. Chromosome 22q11

Di George syndrome. The thymus is affected but not the bone marrow, where B cell production and maturation take place. Hence there is
no reduction in B cell numbers. B cells require T cell help (CD4+ cells) for activation and production of normal quantities of immunoglobulins.
Without this help, B cell activity is reduced.

64
Q

Severe Combined Immunodeficiency

A.	CD3 mutation
B.	IL-2 receptor
C.	Bruton’s tyrosine kinase (Btk) gene
D.	MHC Class II
E.	WASP gene
F.	IFN Receptor 1 gene
G.	Chromosome 22q11
H.	IL12 gene
I.	CD40 Ligand gene
A

B. IL-2 receptor

65
Q

Wiskott-Aldrich Syndrome

A.	CD3 mutation
B.	IL-2 receptor
C.	Bruton’s tyrosine kinase (Btk) gene
D.	MHC Class II
E.	WASP gene
F.	IFN Receptor 1 gene
G.	Chromosome 22q11
H.	IL12 gene
I.	CD40 Ligand gene
A

E. WASP gene

66
Q

Bare lymphocyte syndrome

A.	CD3 mutation
B.	IL-2 receptor
C.	Bruton’s tyrosine kinase (Btk) gene
D.	MHC Class II
E.	WASP gene
F.	IFN Receptor 1 gene
G.	Chromosome 22q11
H.	IL12 gene
I.	CD40 Ligand gene
A

D. MHC Class II

67
Q

X-Linked Agammaglobulinaemia

A. CD40 Ligand gene
B. WASP gene
C. CD3 mutation
D. Bruton’s tyrosine kinase (Btk) gene
E. IL12 gene
F. MHC Class III
G. IL-2 receptor
H. Chromosome 22q11
I. IFN Receptor 1 gene
J. Adenosine Deaminase (ADA) gene
A

D. Bruton’s tyrosine kinase (Btk) gene

68
Q

DiGeorge’s Syndrome

A. CD40 Ligand gene
B. WASP gene
C. CD3 mutation
D. Bruton’s tyrosine kinase (Btk) gene
E. IL12 gene
F. MHC Class III
G. IL-2 receptor
H. Chromosome 22q11
I. IFN Receptor 1 gene
J. Adenosine Deaminase (ADA) gene
A

H. Chromosome 22q11

Di George syndrome. The thymus is affected but not the bone marrow, where B cell production and maturation take place. Hence there is
no reduction in B cell numbers. B cells require T cell help (CD4+ cells) for activation and production of normal quantities of immunoglobulins.
Without this help, B cell activity is reduced.

69
Q

Severe Combined Immunodeficiency

A. CD40 Ligand gene
B. WASP gene
C. CD3 mutation
D. Bruton’s tyrosine kinase (Btk) gene
E. IL12 gene
F. MHC Class III
G. IL-2 receptor
H. Chromosome 22q11
I. IFN Receptor 1 gene
J. Adenosine Deaminase (ADA) gene
A

G. IL-2 receptor

70
Q

Wiskott-Aldrich Syndrome

A. CD40 Ligand gene
B. WASP gene
C. CD3 mutation
D. Bruton’s tyrosine kinase (Btk) gene
E. IL12 gene
F. MHC Class III
G. IL-2 receptor
H. Chromosome 22q11
I. IFN Receptor 1 gene
J. Adenosine Deaminase (ADA) gene
A

B. WASP gene

Wiskott-Aldrich syndrome is an X-linked recessive disease characterised by: thrombocytopenia lymphopenia and depressed cellular immunity immunosuppression eczema malignant lymphoma

71
Q

This region encodes C2, C4 and factor B

A. CD40 Ligand gene
B. WASP gene
C. CD3 mutation
D. Bruton’s tyrosine kinase (Btk) gene
E. IL12 gene
F. MHC Class III
G. IL-2 receptor
H. Chromosome 22q11
I. IFN Receptor 1 gene
J. Adenosine Deaminase (ADA) gene
A

F. MHC Class III

72
Q

Hyper IgM syndrome

A. CD40 Ligand gene
B. WASP gene
C. CD3 mutation
D. Bruton’s tyrosine kinase (Btk) gene
E. IL12 gene
F. MHC Class III
G. IL-2 receptor
H. Chromosome 22q11
I. IFN Receptor 1 gene
J. Adenosine Deaminase (ADA) gene
A

A. CD40 Ligand gene

73
Q

A 25 year old woman comes to her GP about family planning. She is worried because she had an older brother who died before she was born and her grandmother lost two children which she things were both boys. Her GO thinks there may be a genetic disorder in her family affecting the IL-2 receptor.

If correct she has a 50% of inheriting the trait from her mother and being a carrier herself. And there would be a 50% chance of passing it to her children. If inherited, her daughters would be carriers and her sons would require treatment which is usually a bone marrow transplant but gene therapy is sometimes used.

A. Bare lymphocyte syndrome
B. DiGeorge syndrome
C. Reticular dysgenesis
D. TAP deficiency
E. Hyper IgM syndrome
F. Common variable immune deficiency
G. Severe combined immunodeficiency (SCID)
H. Bruton's X linked hypogammaglobulinaemia
I. Selective IgA deficency
A

G. Severe combined immunodeficiency (SCID)

74
Q

A jaundiced 8 month old child presents with failure to thrive, and a history of recurrent infections (viral, bacterial and fungal). On examination there is hepatomegally and blood tests show a raised alk phos and low CD4 count. A defect is found in the proteins that regulate MHC Class II transcription.

A. Bare lymphocyte syndrome
B. DiGeorge syndrome
C. Reticular dysgenesis
D. TAP deficiency
E. Hyper IgM syndrome
F. Common variable immune deficiency
G. Severe combined immunodeficiency (SCID)
H. Bruton's X linked hypogammaglobulinaemia
I. Selective IgA deficency
A

A. Bare lymphocyte syndrome

75
Q

Patient X’s GP writes inquiring about whether to vaccinate. The patient suffers from recurrent respiratory tract infections and has been diagnosed with one of the B-cell maturation defects.

For which one is immunisation still effective?

A. Bare lymphocyte syndrome
B. DiGeorge syndrome
C. Reticular dysgenesis
D. TAP deficiency
E. Hyper IgM syndrome
F. Common variable immune deficiency
G. Severe combined immunodeficiency (SCID)
H. Bruton's X linked hypogammaglobulinaemia
I. Selective IgA deficency
A

I. Selective IgA deficiency

76
Q

For which disorder would a bone marrow transplant be unhelpful but a thymic transplant may provide a cure?

A. Bare lymphocyte syndrome
B. DiGeorge syndrome
C. Reticular dysgenesis
D. TAP deficiency
E. Hyper IgM syndrome
F. Common variable immune deficiency
G. Severe combined immunodeficiency (SCID)
H. Bruton's X linked hypogammaglobulinaemia
I. Selective IgA deficency
A

B. DiGeorge syndrome

77
Q

In acute rejection, release of this substance from CD8+ lymphocytes helps kill target cells

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

K. Granzyme B

78
Q

In acute rejection, these are produced as a result of the activation of neutrophils and macrophages

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

T. Free radicals

79
Q

A difference in this between host and recipient is the main cause of transplant rejection

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

J. HLA type

80
Q

Along with anti-HLA antibodies, the most important screen to ensure a match before transplantation

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

I. ABO blood type

81
Q

Risk factor for chronic allograft rejection

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

P. Hypertension

82
Q

Transplanting an ABO incompatible kidney will result in ___ rejection

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

G. Hyperacute

83
Q

Treatment of acute antibody mediated rejection

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

F. IV Immunoglobulins and Plasmapheresis

84
Q

Treatment of acute cell mediated rejection

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

Q. High dose corticosteroids

85
Q

The 3 most important HLA types to screen for in renal transplantation when matching donor and recipient, in order of importance

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

L. HLA DR > B > A

86
Q

Lymphocyte that responds to foreign HLA DR types

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

D. CD4+ T cells

87
Q

Lymphocyte that responds to foreign HLA A types

A. Interferon gamma
B. HLA DR > A > B
C. HLA A > B > DR
D. CD4+ T cells
E. CD17+ T cells
F. IV Immunoglobulins and Plasmapheresis
G. Hyperacute
H. Diabetes
I. ABO blood type
J. HLA type
K. Granzyme B
L. HLA DR > B > A
M. CD8+ T cells
N. Hypotension
O. Diuretics
P. Hypertension
Q. High dose corticosteroids
R. Amino acids
S. Antibiotics
T. Free radicals
A

M. CD8+ T cells

88
Q

Prevents DNA replication especially of T cells

A. Ribavirin
B. Immunoglobulins
C. Gentamicin
D. Perindopril
E. Cyclophosamide
F. Chloramphenicol
G. Cyproterone acetate
H. Metolazone
I. Ciclosporin
J. Infliximab
K. Thyroxine
L. Dobutamine
M. Prednisolone
N. Mycophenolate mofetil
A

N. Mycophenolate mofetil

Both mycophenolate mofetil and cyclophosphamide prevent lymphocyte proliferation by inhibiting DNA replication. However, mycophenolate mofetil is more selective for T cells, whereas cycophosphamide affects B cells more than T cells

89
Q

Causes a transient increase in neutrophil count

A. Ribavirin
B. Immunoglobulins
C. Gentamicin
D. Perindopril
E. Cyclophosamide
F. Chloramphenicol
G. Cyproterone acetate
H. Metolazone
I. Ciclosporin
J. Infliximab
K. Thyroxine
L. Dobutamine
M. Prednisolone
N. Mycophenolate mofetil
A

M. Prednisolone

90
Q

Monoclonal antibodies inhibiting the actions of cytokines

A. Ribavirin
B. Immunoglobulins
C. Gentamicin
D. Perindopril
E. Cyclophosamide
F. Chloramphenicol
G. Cyproterone acetate
H. Metolazone
I. Ciclosporin
J. Infliximab
K. Thyroxine
L. Dobutamine
M. Prednisolone
N. Mycophenolate mofetil
A

J. Infliximab

91
Q

Can cause gingival hypertrophy as a side effect

A. Ribavirin
B. Immunoglobulins
C. Gentamicin
D. Perindopril
E. Cyclophosamide
F. Chloramphenicol
G. Cyproterone acetate
H. Metolazone
I. Ciclosporin
J. Infliximab
K. Thyroxine
L. Dobutamine
M. Prednisolone
N. Mycophenolate mofetil
A

I. Ciclosporin

92
Q

Administration of this may boost the immune system

A. Ribavirin
B. Immunoglobulins
C. Gentamicin
D. Perindopril
E. Cyclophosamide
F. Chloramphenicol
G. Cyproterone acetate
H. Metolazone
I. Ciclosporin
J. Infliximab
K. Thyroxine
L. Dobutamine
M. Prednisolone
N. Mycophenolate mofetil
A

B. Immunoglobulins

93
Q

Corticosteroids, as well as being directly lymphotoxic in high doses, inhibit T-cell function via which other mechanism?

A. Goodpasture’s syndrome
B. Blocking cytokine synthesis
C. Mycophenolate mofetil
D. Atopic dermatitis
E. Plasmapheresis
F. Bee/wasp venom allergy
G. Infliximab
H. Bone marrow suppression
I. Inhibition of DNA synthesis
J. Polio vaccine
K. Influenza type B vaccine
L. Diptheria, Tetanus, Pertussis vaccine
M. Tacrolimus
A

B. Blocking cytokine synthesis

94
Q

The antiproliferative drug cyclophosphamide inhibits lymphocyte proliferation by which mechanism?

A. Goodpasture’s syndrome
B. Blocking cytokine synthesis
C. Mycophenolate mofetil
D. Atopic dermatitis
E. Plasmapheresis
F. Bee/wasp venom allergy
G. Infliximab
H. Bone marrow suppression
I. Inhibition of DNA synthesis
J. Polio vaccine
K. Influenza type B vaccine
L. Diptheria, Tetanus, Pertussis vaccine
M. Tacrolimus
A

I. Inhibition of DNA synthesis

95
Q

Plasmapheresis may be indicated in which condition?

A. Goodpasture’s syndrome
B. Blocking cytokine synthesis
C. Mycophenolate mofetil
D. Atopic dermatitis
E. Plasmapheresis
F. Bee/wasp venom allergy
G. Infliximab
H. Bone marrow suppression
I. Inhibition of DNA synthesis
J. Polio vaccine
K. Influenza type B vaccine
L. Diptheria, Tetanus, Pertussis vaccine
M. Tacrolimus
A

A. Goodpasture’s syndrome

96
Q

Example of a vaccine that should NOT be given to a severely immunocompromised patient.

A. Goodpasture’s syndrome
B. Blocking cytokine synthesis
C. Mycophenolate mofetil
D. Atopic dermatitis
E. Plasmapheresis
F. Bee/wasp venom allergy
G. Infliximab
H. Bone marrow suppression
I. Inhibition of DNA synthesis
J. Polio vaccine
K. Influenza type B vaccine
L. Diptheria, Tetanus, Pertussis vaccine
M. Tacrolimus
A

J. Polio vaccine

97
Q

A condition where antigen desensitization therapy may be indicated.

A. Goodpasture’s syndrome
B. Blocking cytokine synthesis
C. Mycophenolate mofetil
D. Atopic dermatitis
E. Plasmapheresis
F. Bee/wasp venom allergy
G. Infliximab
H. Bone marrow suppression
I. Inhibition of DNA synthesis
J. Polio vaccine
K. Influenza type B vaccine
L. Diptheria, Tetanus, Pertussis vaccine
M. Tacrolimus
A

F. Bee/wasp venom allergy

98
Q

Prednisolone

A. Anorexia
B. Pneumonitis, pulmonary fibrosis and cirrhosis
C. Hypertension
D. Hair loss
E. Dysrhythmias
F. Bone marrow depression
G. Lethargy
H. Hypertension and reduced GFR
I. Ototoxicity
J. Anaphylaxis
A

C. Hypertension

99
Q

Ciclosporin

A. Anorexia
B. Pneumonitis, pulmonary fibrosis and cirrhosis
C. Hypertension
D. Hair loss
E. Dysrhythmias
F. Bone marrow depression
G. Lethargy
H. Hypertension and reduced GFR
I. Ototoxicity
J. Anaphylaxis
A

H. Hypertension and reduced GFR

100
Q

Azathioprine

A. Anorexia
B. Pneumonitis, pulmonary fibrosis and cirrhosis
C. Hypertension
D. Hair loss
E. Dysrhythmias
F. Bone marrow depression
G. Lethargy
H. Hypertension and reduced GFR
I. Ototoxicity
J. Anaphylaxis
A

F. Bone marrow depression

101
Q

Methotrexate

A. Anorexia
B. Pneumonitis, pulmonary fibrosis and cirrhosis
C. Hypertension
D. Hair loss
E. Dysrhythmias
F. Bone marrow depression
G. Lethargy
H. Hypertension and reduced GFR
I. Ototoxicity
J. Anaphylaxis
A

B. Pneumonitis, pulmonary fibrosis and cirrhosis

For methotrexate (MTX) induced cirrhosis monitor serum procollagen III rather than doing liver biopsy. MTX is given once WEEKLY as maintenance therapy in autoimmune disease; more often and you’re looking at anti-tumour regimens. Remember to replace folate.

102
Q

Immunoglobulin

A. Anorexia
B. Pneumonitis, pulmonary fibrosis and cirrhosis
C. Hypertension
D. Hair loss
E. Dysrhythmias
F. Bone marrow depression
G. Lethargy
H. Hypertension and reduced GFR
I. Ototoxicity
J. Anaphylaxis
A

J. Anaphylaxis